SRR1491293
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1338923 | GTEX | — | 0.955 |
| 2 | SRR1364739 | GTEX | — | 0.943 |
| 3 | SRR1335707 | GTEX | — | 0.940 |
| 4 | SRR1339968 | GTEX | — | 0.939 |
| 5 | SRR818057 | GTEX | — | 0.938 |
| 6 | SRR1345478 | GTEX | — | 0.933 |
| 7 | SRR1352954 | GTEX | — | 0.932 |
| 8 | SRR1359171 | GTEX | — | 0.931 |
| 9 | TCGA-AC-A3BB-01A-21R-A19W-07 | — | A | 0.930 |
| 10 | SRR1391639 | GTEX | — | 0.929 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 30 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| COAGULATION | 0.442 | Binimetinib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.423 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.414 | Remibrutinib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.393 | Inavolisib | — uncovered |
| MYOGENESIS | 0.382 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.354 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.320 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.311 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.309 | Remibrutinib | — uncovered |
| ESTROGEN_RESPONSE_LATE | 0.301 | Idelalisib | — uncovered |
| APOPTOSIS | 0.291 | Idelalisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.284 | Cobimetinib | — uncovered |
| BILE_ACID_METABOLISM | 0.280 | Inavolisib | — uncovered |
| INTERFERON_ALPHA_RESPONSE | 0.254 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.249 | Idelalisib | — uncovered |
| ESTROGEN_RESPONSE_EARLY | 0.247 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.198 | Idelalisib | — uncovered |
| COMPLEMENT | 0.198 | Inavolisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.189 | Inavolisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.186 | Idelalisib | — uncovered |